Want to see IN:KIMS full AI Analyst Report?
Top Page
Krishna Institute of Medical Sciences Limited
(KIMS)
Select Model
Select Model
Rating:52Neutral
Price Target:
₹676.00
▼(-15.21% Downside)
Action:Reiterated
Date:08/17/26
The score is primarily held back by weaker financial quality—margin compression, sharply higher leverage, and deeply negative free cash flow—despite strong revenue growth. Technicals are moderately supportive with price above major moving averages and neutral momentum. Valuation is a major headwind due to the very high P/E and lack of dividend yield data.
Positive Factors
Sustained Revenue Growth
Multi-year revenue expansion indicates increasing demand for KIMS’s hospital and clinical services, rather than reliance on a single short-term improvement. Continued top-line growth can support broader utilization, scale benefits, and reinvestment across its healthcare network over the next several quarters.
Negative Factors
Rapidly Rising Leverage
The sharp increase in debt relative to equity raises financial risk and reduces flexibility as KIMS expands. Higher leverage can constrain future capital allocation, increase sensitivity to earnings volatility, and make the company more dependent on successful execution and continued access to funding.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth
Multi-year revenue expansion indicates increasing demand for KIMS’s hospital and clinical services, rather than reliance on a single short-term improvement. Continued top-line growth can support broader utilization, scale benefits, and reinvestment across its healthcare network over the next several quarters.
Read all positive factors
Krishna Institute of Medical Sciences Limited (KIMS) vs. iShares MSCI India ETF (INDA)
Market Cap
₹293.25B
Dividend YieldN/A
Average Volume (3M)119.60K
Price to Earnings (P/E)138.1
Beta (1Y)0.79
Revenue Growth30.90%
EPS Growth-46.26%
CountryIN
Employees5,013
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)8.39
Shares Outstanding420,006,470
10 Day Avg. Volume15,817
30 Day Avg. Volume119,596
Financial Highlights & Ratios
PEG Ratio-2.77
Price to Book (P/B)11.07
Price to Sales (P/S)6.37
P/FCF Ratio-22.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)10.36
Revenue Forecast (FY)₹51.96B
Krishna Institute of Medical Sciences Limited Business Overview & Revenue Model
Company Description
Krishna Institute of Medical Sciences Limited, known by its brand KIMS Hospitals across India, delivers a broad spectrum of medical and healthcare services. The institution boasts a comprehensive array of specialized fields, including cardiology, ...
How the Company Makes Money
KIMS primarily makes money by delivering hospital and clinical services to patients across its owned/operated hospitals. Its key revenue streams typically include: (1) Inpatient services: room/bed charges, nursing and care services, operating thea...
Krishna Institute of Medical Sciences Limited Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
48
Neutral
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.70B | 39.05B | 30.04B | 24.74B | 21.68B | 16.51B |
| Gross Profit | 20.12B | 21.31B | 18.77B | 15.21B | 13.41B | 10.34B |
| EBITDA | 8.24B | 8.20B | 8.24B | 6.52B | 6.43B | 5.46B |
| Net Income | 3.36B | 2.41B | 3.85B | 3.10B | 3.36B | 3.33B |
Balance Sheet | ||||||
| Total Assets | 66.25B | 77.59B | 57.36B | 38.52B | 29.41B | 19.07B |
| Cash, Cash Equivalents and Short-Term Investments | 1.74B | 898.00M | 1.02B | 1.32B | 1.34B | 1.90B |
| Total Debt | 31.87B | 42.53B | 25.57B | 13.55B | 6.78B | 2.57B |
| Total Liabilities | 40.49B | 52.00B | 33.17B | 17.59B | 10.03B | 4.97B |
| Stockholders Equity | 22.70B | 22.47B | 21.38B | 18.28B | 16.70B | 13.87B |
Cash Flow | ||||||
| Free Cash Flow | -4.69B | -11.15B | -4.27B | -1.26B | -1.42B | 1.54B |
| Operating Cash Flow | 2.85B | 3.13B | 5.82B | 5.21B | 4.32B | 3.24B |
| Investing Cash Flow | -7.17B | -15.69B | -11.16B | -7.53B | -5.47B | -4.12B |
| Financing Cash Flow | 4.57B | 12.55B | 5.43B | 2.17B | 196.42M | 609.99M |
Krishna Institute of Medical Sciences Limited Technical Analysis
Negative
797.25
Price Trends
747.58
Negative
774.34
Negative
724.54
Negative
Market Momentum
-22.85
Negative
43.77
Neutral
40.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KIMS, the sentiment is Negative. The current price of 797.25 is above the 20-day moving average (MA) of 701.92, above the 50-day MA of 747.58, and above the 200-day MA of 724.54, indicating a bearish trend. The MACD of -22.85 indicates Negative momentum. The RSI at 43.77 is Neutral, neither overbought nor oversold. The STOCH value of 40.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KIMS.
Krishna Institute of Medical Sciences Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹338.78B | 60.90 | ― | 0.08% | 21.27% | 4.09% | |
62 Neutral | ₹350.80B | 42.70 | ― | 0.26% | 57.80% | 4.07% | |
60 Neutral | ₹560.90B | 53.06 | ― | 0.13% | 17.50% | 20.65% | |
59 Neutral | ₹1.12T | 53.61 | ― | 0.26% | 17.20% | 32.79% | |
55 Neutral | ₹825.37B | 56.45 | ― | 0.24% | 15.96% | 26.87% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | ₹293.25B | 138.15 | ― | ― | 30.90% | -46.26% |
* General Sector Average
IN:KIMS
Krishna Institute of Medical Sciences Limited
698.20
-36.10
-4.92%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
7,800.00
-40.04
-0.51%
IN:FORTIS
Fortis Healthcare Ltd.
742.95
-311.33
-29.53%
IN:MAXHEALTH
Max Healthcare Institute Ltd
848.00
-339.64
-28.60%
IN:MEDANTA
Global Health Limited
1,260.00
-114.91
-8.36%
IN:NH
Narayana Hrudayalaya Ltd.
1,716.55
-78.96
-4.40%
Krishna Institute of Medical Sciences Limited Corporate Events
KIMS Schedules Analyst and Investor Meet at Anand Rathi G-200 Summit 2026
Sep 15, 2026
Krishna Institute of Medical Sciences Limited has notified the stock exchanges that it will participate in the Anand Rathi Annual Flagship Conference G-200 Summit 2026 in Mumbai on September 22, 2026. The engagement will be held as a group meeting...
KIMS Discloses AGM Voting Results and Scrutinizer’s Report
Aug 30, 2026
Krishna Institute of Medical Sciences Limited has reported to the BSE and NSE the voting results and scrutinizer’s report for its 24th Annual General Meeting held on August 27, 2026, which was conducted via video conferencing and other audio...
KIMS Takes Over Operations of Hyderabad’s Arete Hospitals, Secures Option to Acquire Business
Aug 20, 2026
KIMS has entered into an exclusive Operations and Management Agreement with Aurevia Hospitals Private Limited to run and control Arete Hospitals in Gachibowli, Hyderabad for an initial five-year term, extendable by another five years. Under this a...
KIMS Allots 7.7 Million Preferential Warrants to Promoters, Lifting Promoter Stake
Aug 19, 2026
Krishna Institute of Medical Sciences Limited has allotted 7,702,182 fully convertible warrants on a preferential basis to promoters Dr. Abhinay Bollineni and Mr. Adwik Bollineni, and promoter group entity Bharas Ventures LLP, after receiving abou...
Krishna Institute of Medical Sciences Announces Virtual 24th Annual General Meeting
Aug 6, 2026
Krishna Institute of Medical Sciences Limited has announced that its 24th Annual General Meeting will be held on August 27, 2026, at 4:00 p.m. IST, and will be conducted through video conferencing and other audio-visual means in line with virtual ...
KIMS Sets August 27, 2026 Virtual AGM to Clear FY26 Accounts and Expand Intra-Group Financing Scope
Aug 5, 2026
Krishna Institute of Medical Sciences Limited has scheduled its 24th Annual General Meeting for August 27, 2026, to be held via video conferencing and other audio-visual means, where members will review and adopt the audited standalone and consoli...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.